Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 80/100

Failure Rate

34.9%

30 terminated/withdrawn out of 86 trials

Success Rate

50.0%

-36.5% vs industry average

Late-Stage Pipeline

87%

75 trials in Phase 3/4

Results Transparency

3%

1 of 30 completed trials have results

Key Signals

6 recruiting1 with results29 withdrawn

Enrollment Performance

Analytics

Phase 3
70(81.4%)
Phase 2
8(9.3%)
Phase 4
5(5.8%)
N/A
3(3.5%)
86Total
Phase 3(70)
Phase 2(8)
Phase 4(5)
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (86)

Showing 20 of 86 trials
NCT03540355Phase 3Completed

Efficacy and Safety of Cipros 20 Association on Dyslipidemia Treatment

Role: lead

NCT02493322Phase 3Withdrawn

Efficacy and Safety of Olmesartan Associated With Chlorthalidone in Essential Arterial Hypertension Control

Role: lead

NCT05640232Phase 3Recruiting

Efficacy and Safety of CDE100 in the Treatment of Menstrual Cramp Pain Associated With Primary Dysmenorrhea

Role: lead

NCT04185441Phase 3Completed

Efficacy and Safety of Tanzânia Association in the Treatment of Erectile Dysfunction Associated With Benign Prostatic Hyperplasia

Role: lead

NCT02483936Phase 3Withdrawn

Efficacy and Safety of Olmesartan Associated With Chlorthalidone Versus Benicar HCT® in Essential Hypertension Control

Role: lead

NCT03527069Phase 3Completed

Efficacy and Safety of Cipros 10 Association on the Isolated Hypertriglyceridemia and Dyslipidemia Treatment

Role: lead

NCT04670666Phase 3Recruiting

Efficacy and Safety of Madalena Association in the Treatment of Type II Diabetes Mellitus

Role: lead

NCT05028140Phase 3Recruiting

Efficacy and Safety of Piemonte Association in the Treatment of Type II Diabetes Mellitus

Role: lead

NCT04594018Phase 3Recruiting

Efficacy and Safety of Finlândia Hair Lotion Association on Androgenetic Alopecia

Role: lead

NCT04602754Phase 3Recruiting

Efficacy and Safety of Berlim 25/20 Association in the Treatment of Type II Diabetes Mellitus and Dyslipidemia.

Role: lead

NCT07030101Phase 3Not Yet Recruiting

A Study to Investigate Efficacy and Safety of a TCA108 in Participants ≥18 Years With Uncontrolled Hypertension

Role: lead

NCT05811390Not ApplicableCompleted

Non-surgical Treatment of Periimplantitis - Conventional Hand Instrumentation Versus Air-polishing

Role: collaborator

NCT04666714Phase 3Recruiting

Efficacy and Safety of Praga Formulation in the Treatment of Neuropathic Pain

Role: lead

NCT06555549Not ApplicableNot Yet Recruiting

Efficacy and Safety of DEH113 in the Treatment of Menstrual Cramp Pain in Primary Dysmenorrhea: a Pilot Study

Role: lead

NCT06268054Phase 3Not Yet Recruiting

Efficacy and Safety of DEH113 in the Treatment of Menstrual Cramp Pain Associated With Primary Dysmenorrhea

Role: lead

NCT06272409Phase 3Not Yet Recruiting

Efficacy and Safety of DEP114 in the Treatment of Moderate to Severe Persistent Allergic Rhinitis in Children.

Role: lead

NCT03235232Phase 3Completed

BREMEN Eye Drops Versus Combigan for Open-angle Glaucoma or Intraocular Hypertension

Role: lead

NCT06264414Phase 3Not Yet Recruiting

Efficacy and Safety of the DTT106 in the Treatment of Erectile Dysfunction Associated With Benign Prostatic Hyperplasia

Role: lead

NCT05772338Not ApplicableUnknown

Efficacy and Safety of BNP105 in the Treatment of Recurrent Aphthous Stomatitis

Role: lead

NCT05800392Phase 4Completed

Efficacy and Safety of DEC103 in Pain Control Associated to Intrauterine Device (IUD) Insertion

Role: lead